Kaiser Health News
Pharmacy benefit managers switched to virtual audits during the pandemic, which increased reviews, payment denials and their profits.
Studies show a broad array of casual and close ties can lead to better physical and psychological well-being in older adults — and a longer lifespan.
A Pfizer win in a lawsuit against the federal government could cost taxpayers billions of dollars and erase an important control on pharma marketing after decades of regulatory erosion and soaring drug prices, say health policy analysts.
Delta has kept some of the most successful mutations found in earlier variants, but also contains new genetic changes that enable it to spread twice as fast.
Health systems, clinics and private practices pivoted swiftly to telemedicine when the COVID-19 pandemic hit, but video services were not prepared for a titanic influx of users.
Smoke and heat in the West are driving people to seek refuge at libraries, movie theaters, museums and other indoor venues.
As more heatstroke patients arrived at hospitals in Washington, doctors used human body bags filled with ice and water to quickly immerse and cool several elderly people.
Booster shots are likely to be here before long because of the outdated, 60-year-old basic standard the Food and Drug Administration uses to authorize medicines for sale.
Only 3,600 of an estimated 16 million Medicare beneficiaries eligible for a two-year diabetes prevention program have actually signed up since Medicare started covering the program in 2018.